Creo Medical Share Price | |
---|---|
Price | 35.00 |
Bid | 34.50 |
Ask | 35.50 |
Change | -0.25 (-0.71%) |
Volume | 373,908 |
Open | 35.25 |
High | 35.25 |
Low | 34.75 |
Prev. Close | 35.25 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 361.48m |
Market Capitalisation | £126.52m |
Market Size | 10,000 |
52 Week High | 49.00 |
52 Week High Date | 02-Jan-2024 |
52 Week Low | 23.25 |
52 Week Low Date | 08-Jun-2023 |
# Trades | 38 |
---|---|
Vol. Sold | 13,677 |
Sold Value | £4.81k |
Vol. Bought | 253,944 |
Bought Value | £88.62k |
PE Ratio | -2.417728 |
Earnings | -14.4764 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
03-May-24 | 16:31:26 | 34.625 | 100,000 | Unknown* | 34.50 | 35.50 | 34.63k | O Ordinary Delayed publication |
03-May-24 | 16:27:14 | 35.48 | 56,000 | Buy* | 34.50 | 35.50 | 19.87k | O Ordinary |
03-May-24 | 16:20:55 | 35.45 | 530 | Buy* | 34.50 | 35.50 | 187.89 | O Ordinary |
03-May-24 | 16:11:56 | 35.45 | 200 | Buy* | 34.50 | 35.50 | 70.90 | O Ordinary |
03-May-24 | 16:08:56 | 35.50 | 1,408 | Buy* | 34.50 | 35.50 | 499.84 | O Ordinary Trade was executed as an SI |
03-May-24 | 16:08:56 | 35.50 | 281 | Buy* | 34.50 | 35.50 | 99.76 | O Ordinary Trade was executed as an SI |
03-May-24 | 16:04:32 | 34.995 | 10,000 | Buy* | 34.50 | 35.00 | 3,500 | O Ordinary |
03-May-24 | 16:01:22 | 34.75 | 6,287 | Unknown* | 34.50 | 35.00 | 2,185 | O Ordinary |
03-May-24 | 15:53:24 | 35.00 | 50,000 | Buy* | 34.50 | 35.00 | 17.50k | O Ordinary |
03-May-24 | 15:52:25 | 34.995 | 10,000 | Buy* | 34.50 | 35.00 | 3,500 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
13-Mar-23 | 09-Mar-23 | Buy | Ivonne Cantu held the position of Independent Non-Executive Director at the time of this trade.Ivonne Cantu | 20.00 | GBX | 125,000 | 125,000 |
13-Mar-23 | 09-Mar-23 | Buy | John Bradshaw held the position of Independent Non-Executive Director at the time of this trade.John Bradshaw | 20.00 | GBX | 1,265,135 | 1,371,082 |
13-Mar-23 | 09-Mar-23 | Buy | David Gerard Woods held the position of Executive Director at the time of this trade.David Gerard Woods | 20.00 | GBX | 415,255 | 440,255 |
13-Mar-23 | 09-Mar-23 | Buy | Christopher Paul Hancock held the position of Chief Technology Officer at the time of this trade.Christopher Paul Hancock | 20.00 | GBX | 383,171 | 4,802,352 |
13-Mar-23 | 09-Mar-23 | Buy | Richard John Rees held the position of CFO at the time of this trade.Richard John Rees | 20.00 | GBX | 2,715,322 | 2,805,902 |